Skip to main content

Table 3 Acute and late gastrointestinal toxicity

From: Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial

 

Grade 1

Grade 2

Grade 3

Grade 4

Diarrhea

 End of RT

18.9 %

2.7 %

–

–

 13 weeks

13.9 %

–

–

–

 6 months

5.9 %

2.9 %

–

–

 12 months

–

–

–

–

 18 months

3.2 %

–

–

–

 24 months

–

–

–

–

Enteritis

 End of RT

13.5 %

2.7 %

–

–

 13 weeks

2.8 %

–

–

–

 6 months

2.9 %

2.9 %

–

–

 12 months

–

–

–

–

 18 months

–

–

–

–

 24 months

–

–

–

–

Proctitis

 End of RT

13.5 %

5.4 %

–

–

 13 weeks

2.8 %

–

–

–

 6 months

–

–

–

–

 12 months

2.9 %

–

–

–

 18 months

–

–

–

–

 24 months

–

–

–

–

  1. RT radiotherapy